Research in Social and Administrative Pharmacy
Volume 5, Issue 3 , Pages 211-224, September 2009

The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan

  • Li-Chia Chen, Ph.D.

      Affiliations

    • Present address: Graduate Institute of Clinical Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • ,
  • Ellen I. Schafheutle, M.Sc., M.Res., Ph.D.

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 161 275 7493; fax: +44 161 275 2416.
  • ,
  • Peter R. Noyce, Ph.D.

School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, 1st Floor, Stopford Building, Oxford Road, Manchester, M13 9PT, UK

published online 02 February 2009.

Abstract 

Background

Taiwan's National Health Insurance's (NHI) generous coverage and patients' freedom to access different tiers of medical facilities have resulted in accelerating outpatient care utilization and costs. To deter nonessential visits and encourage initial contact in primary care (physician clinics), a differential co-payment was introduced on 15th July 2005. Under this, patients pay more for outpatient consultations at “higher tiers” of medical facilities (local community hospitals, regional hospitals, medical centers), particularly if accessed without referral.

Objectives

This study explored the impact of this policy on outpatient medical activities and expenditures, different co-payment groups, and tiers of medical facilities.

Methods

A segmented time-series analysis on regional weekly outpatient medical claims (January 2004 to July 2006) was conducted. Outcome variables (number of visits, number of outpatients, total cost of outpatient care) and variables for cost structure were stratified by tiers of medical facilities and co-payment groups. Analysis used the auto-regressive integrated moving-average model in STATA 9.0.

Results

The overall number of outpatient visits significantly decreased after policy implementation due to a reduction in the number of patients using outpatient facilities, but total costs of care remained unchanged. The policy had its greatest impact on the number of visits to regional and local community hospitals but had no influence on those to the medical centers. Medical utilization in physician clinics decreased due to an audit of reimbursement declarations. Overall, the policy failed to encourage referrals from primary care to higher tiers because there was no obvious shifting of medical utilization and costs reversely.

Conclusions

Differential co-payment policy decreased total medication utilization but not costs to NHI. The results suggest that the increased level of co-payment charge and the strategy of a single cost-sharing policy are not sufficient to promote referrals within the system. To achieve an effective co-payment policy, further research is needed to explore how patients' out-of-pocket payment affects medical utilization and which forces (not susceptible to co-payment) act in tertiary facilities.

Keywords: Co-payment, Referral system, Medical utilization, Health-care cost

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 25.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1551-7411(08)00089-2

doi:10.1016/j.sapharm.2008.08.003

Research in Social and Administrative Pharmacy
Volume 5, Issue 3 , Pages 211-224, September 2009